Sangamo Therapeutics (SGMOQ) Other Non-Current Assets (2010 - 2025)

Sangamo Therapeutics' Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $871000.0 for Q4 2025.

• On a quarterly basis, Other Non-Current Assets fell 0.91% year-over-year to $871000.0 in Q4 2025; TTM through Dec 2025 was $871000.0, a 0.91% decrease from a year earlier, with the FY2025 full-year figure at $871000.0, down 0.91% from the prior year.
• Other Non-Current Assets fell to $871000.0 in Q4 2025 per SGMOQ's latest filing, from $890000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $17.4 million in Q2 2023 and bottomed at $871000.0 in Q4 2025.
• The 5-year median for Other Non-Current Assets is $1.5 million (2021), against an average of $7.3 million.
• Biggest YoY gain for Other Non-Current Assets was 1062.53% in 2023; the steepest drop was 91.19% in 2023.
• Year by year, Other Non-Current Assets stood at $15.3 million in 2021, then grew by 11.12% to $17.0 million in 2022, then tumbled by 91.19% to $1.5 million in 2023, then plunged by 41.4% to $879000.0 in 2024, then dropped by 0.91% to $871000.0 in 2025.
• Per Business Quant, the three latest SGMOQ Other Non-Current Assets figures stand at $871000.0 (Q4 2025), $890000.0 (Q2 2025), and $1.5 million (Q1 2025).